Evaluation of milk protein concentrate (MPC) on weight-loss

Evaluation of milk protein concentrate (MPC) on serum levels of glucose, lipid profile, insulin, adipocytokines and body composition in obese women on a weight-loss diet

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201223049804N1

Enrollment

Registered

2021-01-10

Start date

2022-04-03

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group: Isocaleric weight loss diet and milk protein concentration (MPC) powders will be prescribed. Each of intervention group subjects, will receive 30 gram milk protein

Eligibility

Sex/Gender

Female

Age

18 Years to 48 Years

Inclusion criteria

Inclusion criteria: aged 18 years and older female BMI range of 30 to 40 kg/m2 absence of menopause, lactation and pregnancy food allergies not having eating disorders, particularly binge eating disorder (BED), bulimia not having cancer, hepatic, renal, thyroid and gastrointestinal disorders no surgery for weight loss no weight loss over the past 6 months no taking herbs and drug that reduce appetite and weight and vitamin-mineral supplements

Exclusion criteria

Exclusion criteria: become pregnant during study unwilling to continue changes in diet during the study period no consumption of powders exceed 10% of total administered powders

Design outcomes

Primary

Measure	Time frame
Leptin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Adiponectin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Body Composition. Timepoint: Before and 2 months after the intervention. Method of measurement: Body Composition Analyzer.;Waist circumference. Timepoint: Before and 2 months after the intervention. Method of measurement: Tape measure.;Body Mass Index. Timepoint: Before and 2 months after the intervention. Method of measurement: calculated as body weight(kg)divided by the height in meters square.	—

Measure

Time frame

Leptin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Adiponectin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Body Composition. Timepoint: Before and 2 months after the intervention. Method of measurement: Body Composition Analyzer.;Waist circumference. Timepoint: Before and 2 months after the intervention. Method of measurement: Tape measure.;Body Mass Index. Timepoint: Before and 2 months after the intervention. Method of measurement: calculated as body weight(kg)divided by the height in meters square.

—

Secondary

Measure	Time frame
Fasting Blood Sugar. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Lipid Profile. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Fasting Plasma Insulin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Appetite. Timepoint: Before and 2 months after the intervention. Method of measurement: Questionnaire.	—

Measure

Time frame

Fasting Blood Sugar. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Lipid Profile. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Fasting Plasma Insulin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Appetite. Timepoint: Before and 2 months after the intervention. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Elahikhah

Ahvaz University of Medical Sciences

mahsa.elahikhah@gmail.com+98 61 3333 9092

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026